Euro-EWING99 long-term analysis defines outcomes in 3,395 patients with Ewing sarcoma
Five-year progression-free and overall survival were 55.4% and 64.6%, with metastatic status and histologic response remaining major prognostic factors.
Tag
The Radiation Oncology Feed
For radiation oncologists · physicists · RTTs · dosimetrists